$ANAC Anacor Pharmaceuticals, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Anacor Pharmaceuticals, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Anacor Pharmaceuticals, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Aberdare Ventures II, L.P. | 10% Owner | 1,751,936 | 0 | Dec 01 2010 | |||
| Bell Graeme | Executive VP and CFO | 0 | 0 | Jun 24 2016 | |||
| BERNS PAUL L | President and CEO | 0 | 0 | Jun 24 2016 | |||
| BERNS PAUL L | President and CEO | 346,260 | 0 | Feb 05 2015 | |||
| CARE CAPITAL INVESTMENTS II LP | 10% Owner | 1,558,104 | 0 | Dec 01 2010 | |||
| Chanda Sanjay | SVP, Drug Development | 29,087 | 0 | Mar 04 2015 | |||
| GLAXOSMITHKLINE PLC | 10% Owner | 2,771,374 | 0 | Nov 24 2010 | |||
| Heyman Irwin A | Senior VP, Drug Development | 0 | 0 | Mar 14 2012 | |||
| Hove Anders D | Director | 0 | 0 | Jun 24 2016 | |||
| Hove Anders D | Director | 2,725,535 | 0 | Sep 30 2014 | |||
| Hove Anders D | Director | 0 | 0 | May 27 2011 | |||
| Hove Anders D | Director | 4,625,535 | 0 | Jun 10 2013 | |||
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 0 | 0 | Jun 24 2016 | |||
| IPPOLITO VINCENT P | EVP & Chief Commercial Officer | 79,603 | 0 | Feb 05 2015 | |||
| KLINGENSTEIN PAUL H | Director | 1,751,936 | 0 | Dec 01 2010 | |||
| KLINGENSTEIN PAUL H | Director | 0 | 0 | Jun 01 2012 | |||
| KLINGENSTEIN PAUL H | Director | 0 | 0 | May 30 2014 | |||
| Leonard Keith R | Director | 0 | 0 | Jun 24 2016 | |||
| Leonard Keith R | Director | 0 | 0 | May 30 2014 | |||
| LESCHLY MARK | Director | 0 | 0 | Jun 24 2016 | |||
| LESCHLY MARK | Director | 0 | 0 | Aug 29 2014 | |||
| LESCHLY MARK | Director | 0 | 0 | Apr 04 2011 | |||
| LESCHLY MARK | Director | 0 | 0 | Jun 07 2013 | |||
| Maples Kirk R | SVP, Program Management | 7,220 | 0 | Jun 02 2015 | |||
| Maples Kirk R | SVP, Program Management | 9,620 | 0 | Feb 05 2015 | |||
| Markham Richard J | Director | 1,558,104 | 0 | Dec 01 2010 | |||
| Markham Richard J | Director | 0 | 0 | May 26 2011 | |||
| Parker Geoffrey M. | Executive Vice President & CFO | 173,000 | 0 | Mar 23 2015 | |||
| Parker Geoffrey M. | Executive Vice President & CFO | 94,840 | 0 | Feb 05 2015 | |||
| Parker Geoffrey M. | Senior Vice President and CFO | 0 | 0 | Mar 14 2012 | |||
| PERRY DAVID P | President and CEO | 361,306 | 0 | Mar 06 2014 | |||
| Plattner Jacob j | Senior VP, Research | 17,840 | 0 | May 15 2015 | |||
| Plattner Jacob j | Senior VP, Research | 5,020 | 0 | Feb 05 2015 | |||
| RHO MANAGEMENT TRUST I | 10% Owner | 0 | 0 | Dec 22 2011 | |||
| RHO VENTURES IV LP | 10% Owner | 243,815 | 0 | Nov 18 2013 | |||
| RHO VENTURES IV QP LP | 10% Owner | 0 | 0 | Feb 05 2014 | |||
| RIEFLIN WILLIAM JL | Director | 0 | 0 | Jun 24 2016 | |||
| RIEFLIN WILLIAM JL | Director | 0 | 0 | Apr 04 2011 | |||
| RIEFLIN WILLIAM JL | Director | 0 | 0 | Jun 07 2013 | |||
| RIEFLIN WILLIAM JL | Director | 0 | 0 | May 30 2014 | |||
| Rodriguez Carmen R | Snr VP Reg Afrs & Qual. Assur. | 7,020 | 0 | May 14 2015 | |||
| Shapiro Lucy | Director | 0 | 0 | Jun 24 2016 | |||
| Shapiro Lucy | Director | 397,416 | 0 | Dec 01 2010 | |||
| Shapiro Lucy | Director | 0 | 0 | Dec 29 2014 | |||
| Sullivan Ryan T | EVP and General Counsel | 0 | 0 | Jun 24 2016 | |||
| Sullivan Ryan T | Sr. VP and General Counsel | 30,865 | 0 | Feb 05 2015 | |||
| VENROCK ASSOCIATES IV L P | 10% Owner | 2,625,535 | 0 | Dec 02 2010 | |||
| VENROCK ASSOCIATES IV L P | 10% Owner | 3,575,535 | 0 | Nov 19 2013 | |||
| VENROCK ASSOCIATES V LP | 10% Owner | 3,725,535 | 0 | Sep 24 2012 | |||
| WIERENGA WENDALL D | Director | 0 | 0 | Jun 24 2016 | |||
| Zane Lee | SVP and Chief Medical Officer | 0 | 0 | Jun 24 2016 |